Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||0.54%||164.82||0.7%||$998.60m|
|MRK||Merck & Co., Inc.||1.40%||73.05||0.7%||$880.20m|
|LLY||Eli Lilly & Co.||1.65%||232.06||1.1%||$598.53m|
|BMY||Bristol-Myers Squibb Co.||0.78%||60.62||1.0%||$573.53m|
|CRVS||Corvus Pharmaceuticals, Inc.||-6.14%||7.03||0.7%||$143.77m|
|RPRX||Royalty Pharma Plc||2.32%||37.13||0.1%||$120.28m|
|NVO||Novo Nordisk A/S||1.24%||102.12||0.1%||$102.45m|
Principia Biopharma is a private, pre-clinical stage company initially focused on the discovery and development of differentiated small molecule drugs targeting inflammatory/autoimmune diseases as well as cancer. The company expects to submit an IND for its lead program in 2013 and continues to invest in additional programs and its reversible covalent platform.